News Digest / Ticker: STIM

Ticker: STIM

08:03am, Tuesday, May 06, 2025

Neuronetics Reports 84% Revenue Growth Amid Increased Losses and Rising Operating Expenses

Neuronetics, Inc. (NASDAQ: STIM) - Quarterly Review (Ending March 31, 2025) Neuronetics, Inc., a leader in neuroscience and manufacturer of the NeuroStar Advanced Therapy System, reported substantial growth in total revenues but continued to face operating losses. Here’s a concise overview of the...